Logo Image
News
OncClubAll Oncology NewsClinical Trials in Focus
Media
InsightsMedNews WeekOncChatsOncLive News Network®OncLive TVPeer ExchangePodcastsRapid ReadoutsShorts
Conferences
Conference CoverageConference Listing
Events
Giants of Cancer CareCME/CEScientific InterchangesState of the Science SummitNational Fellows ForumWebinars
More
Partners
Publications
All PublicationsSupplements
Resources
Consensus ViewpointsOncLive AppInteractive ToolsSponsored
Biomarker Consortium

Subscribe

  • News
  • Media
  • Conferences
  • Events
  • Partners
  • Publications
  • Resources
  • Biomarker Consortium
  • Subscribe
  • AI for Oncology
  • Biosimilars
  • Brain Cancer
  • Breast Cancer
    • HER2+ Breast Cancer
  • CAR T-Cell Therapy
  • Disparities in Cancer Care
  • Gastrointestinal Cancer
    • Pancreatic Cancer
    • Hepatocellular Carcinoma
    • Gastric Cancer
    • Colorectal Cancer
  • Genitourinary Cancers
    • Urothelial Cancer
    • Prostate Cancer
  • Global Oncology
  • Graft-vs-Host Disease
  • Gynecologic Oncology
    • Ovarian Cancer
  • Head & Neck Cancers
  • Hematologic Oncology
    • Chronic Lymphocytic Leukemia
    • Non-Hodgkin Lymphoma
    • Mantle Cell Lymphoma
    • Multiple Myeloma
    • Myeloproliferative Neoplasms
  • Immuno-Oncology
  • Lung Cancer
  • Melanoma & Skin Cancer
  • Oncology Business Management
  • Pediatric Oncology
  • Precision Medicine in Oncology®
  • Sarcomas
  • Supportive Care
Spotlight -
The OncLive Insider app is live!|
CME Opportunities
Advertisement

Recent Advances in MDS and CML

EP. 1: Introduction: Treatment Landscape of MDS

January 9th 2014

EP. 2: Discontinuation of Treatment With TKIs in CML

January 9th 2014

EP. 3: Frontline Treatment of Chronic Myelogenous Leukemia

January 9th 2014

EP. 4: Second-Generation Tyrosine Kinase Inhibitors in CML

January 9th 2014

EP. 5: Treatment Selection for Resistant or Intolerant CML

January 9th 2014

EP. 6: Hypomethylating Agents in the Treatment of High-Risk MDS

January 9th 2014

EP. 7: Role of Genetic Testing in Myelodysplastic Syndromes

January 9th 2014

EP. 8: Defining and Predicting Response to HMAs in MDS

January 9th 2014

EP. 9: Treatment of MDS Refractory to Hypomethylating Agent

January 9th 2014

EP. 10: Current and Future Treatment Landscape for MDS

January 9th 2014

EP. 11: Novel Agents and Treatment Strategies in MDS

January 9th 2014

EP. 12: Oral Azacitidine and Lenalidomide Combinations in MDS

January 9th 2014

EP. 13: Final Thoughts on Clinical Advances in MDS and CML

January 9th 2014
Advertisement
Advertisement

Trending on OncLive

1

International Intel: A Glance at the Top Global Breast Cancer News From April-June 2026

2

Pembrolizumab Monotherapy Improves PFS vs Chemotherapy in Frontline dMMR Endometrial Cancer

3

Neoadjuvant Cemiplimab Elicits Responses and Surgical Benefit in HHI-Naive BCC of the Head and Neck

4

CAR T-Cell Engineering Produces Early Efficacy Signals in Glioblastoma

5

Experts Unpack Crucial Hematologic Oncology Data From ASCO 2026

  • Advertise
  • About OncLive
  • Editorial Board
  • MJH Life Sciences brands
  • Contact Us
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo
Download on Apple
Download on Google Play

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us